The present invention relates to 1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone salts, specifically to the hydrochloride and to the maleate, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.本發明涉及1-(4-(2-((1-(3,4-二氟苯基)-1H-吡唑-3-基)甲氧基)乙基)呱嗪-1-基)乙酮鹽,具體地涉及其鹽酸鹽和馬來酸鹽,涉及含有它們的藥物組合物,以及涉及其在σ受體相關疾病的治療和/或預防中的用途。